Found 1818 results
[ Author(Asc)] Title Type Year
A B C D E F G H I J K L M N O P Q R S T U V W X Y Z 
V
E. Vardas, Kaleebu, P., Bekker, L., Hoosen, A., Chomba, E., Johnson, P., Anklesaria, P., Birungi, J., Barin, B., Boaz, M., Cox, J., Lehrman, J., Stevens, G., Gilmour, J., Tarragona, T., Hayes, P., Lowenben, S., Kizito, E., Fast, P., Heald, A., and Schmidt, C., A Phase 2 Study to Evaluate the Safety and Immunogenicity of a Recombinant HIV Type 1 Vaccine Based on Adeno-Associated Virus, AIDS Res Hum Retroviruses, vol. 26, pp. 933-942, 2010.
E. Vardas, Pantaleo, G., Bart, P. A., Robinson, A., Pieterse, C., Thomas, R., McIntyre, J., Gray, G., Bogoshi, M., Mayaphi, S., Fast, P., Schmidt, C., Gilmour, J., Tarragona, T., Smith, C., and Dally, L., Safety and Immunogenicity of MVA.HIVA by 3 Different Routes, in AIDS Vaccine 2005 International Conference, Montreal, Quebec, Canada, 2005.
P. VanVeldhuisen, Sharma, G., and Bogenschutz, M., Predictors of Agreement Between Hair Analysis and Self-Report of Drug Use, in 77th Annual Meeting of the College on Problems of Drug Dependence (CPDD), Phoenix, AZ, 2015.
P. Van Veldhuisen, Walters, M., Sawada, T., Levine, P., Wilks, R., Hanchard, B., and Hisada, M., Seroincidence of HTLV-I infection and characterization of seroconverters in Jamaican food handlers, J Acquir Immune Defic Syndr, vol. 33, pp. 387-392, 2003.
P. Van Veldhuisen, Sawada, T., Miley, W., Levine, P. H., Hanchard, B., Cranston, B., and Hisada, M., Evaluation of Predictive Markers of HTLV-I Associated Disease in Jamaica, in The 12th International Conference on Human Retrovirology: HTLV and Related Viruses, Montego Bay, Jamaica, 2005.
K. - J van Holthe, Ho, P., Stablein, D., Harmon, W., and Baum, M., Outcome of Renal Transplantation for Wilms' Tumor and Denys-Drash Syndrome: A Report of the North American Pediatric Renal Transplant Cooperative Study, Pediatr Transplant, vol. 9, pp. 305-310, 2005.
L. Van Damme, Niruthisard, S., Atisook, R., Boer, K., Dally, L., Laga, M., Lange, J. M., Karam, M., and Perriens, J. H., Safety evaluation of nonoxynol-9 gel in women at low risk of HIV infection, AIDS, vol. 12, pp. 433-7, 1998.
F. van Asten, Simmons, M., Singhal, A., Keenan, T. D., Ratnapriya, R., Agrón, E., Clemons, T. E., Swaroop, A., Lu, Z., and Chew, E. Y., A Deep Phenotype Association Study Reveals Specific Phenotype Associations with Genetic Variants in Age-related Macular Degeneration: Age-Related Eye Disease Study 2 (AREDS2) Report No. 14, Ophthalmology, 2017.
F. van Asten, Chiu, C. Y., Agron, E., Clemons, T. E., Ratnapriya, R., Swaroop, A., Klein, M. L., Fan, R., Chew, E. Y., and Age-Related Eye Disease Study 2 Research Group, No CFH or ARMS2 Interaction with Omega-3 Fatty Acids, Low versus High Zinc, or β-Carotene vs Lutein and Zeaxanthin on Progression of Age-Related Macular Degeneration in the Age-Related Eye Disease Study 2: Age-Related Eye Disease Study 2 Report No. 18, Ophthalmology, vol. 126, no. 11, p. 1541, 2019.
T
L. M. Turcotte, DeFor, T. E., Newell, L. F., Cutler, C. S., Verneris, M. R., Wu, J., Howard, A., MacMillan, M. L., Antin, J. H., Vercellotti, G. M., Slungaard, A., Blazar, B. R., Weisdorf, D. J., Panoskaltsis-Mortari, A., and Holtan, S. G., Donor and Recipient Plasma Follistatin Levels are Associated with Acute GvHD in Blood and Marrow Transplant Clinical Trials Network 0402, Bone Marrow Transplant, vol. 53, no. 1, pp. 64-68, 2018.
E. T. Tsilou, Thompson, D., Lindblad, A. S., Reed, G. F., Rubin, B., Gahl, W., Thoene, J., Del Monte, M. A., Schneider, J. A., Granet, D. B., and Kaiser-Kupfer, M. I., A multicenter randomized double-masked clinical trial of a new formulation of topical Cysteamine for the treatment of Corneal Cystine Crystals in cystinosis, Brit J Ophthalmol, vol. 87, pp. 28-31, 2003.
E. Trujillo, Young, L., Chertow, G., Randall, S., Clemons, T., Jacobs, D., and Robinson, M., Metabolic and monetary costs of avoidable parenteral nutritional use, J Parenter Enteral Nutr, vol. 23, pp. 109-13, 1999.
J. D. Troy, Atallah, E., Geyer, J. T., and Saber, W., Myelodysplastic Syndromes in the United States: An Update for Clinicians, Ann Med, vol. 46, pp. 283-289, 2014.
K. E. Trocin, Weinstein, N. I., Oga, E. A., Mark, K. S., and Coleman-Cowger, V. H., Prenatal Practice Staff Perceptions of Three Substance Use Screening Tools for Pregnant Women., J Addict Med, vol. 14, no. 2, pp. 139-144, 2020.
M. Trivedi, Greer, T. L., Grannemann, B. D., Church, T. S., Somoza, E., Blair, S. N., Szapocznik, J., Stoutenberg, M., Rethorst, C., Warden, D., Ring, K., Walker, R., Morris, D. W., Kosinski, A. S., Kyle, T., Marcus, B., Crowell, B., Oden, N., and Nunes, E., Stimulant Reduction Intervention Using Dosed Exercise (STRIDE) - CTN 0037: Study Protocol for a Randomized Controlled Trial, Trials, vol. 19, pp. 206-231, 2011.
E. Trimble and Schoenfeldt, M., Clinical Trials Referral Resource. Current Treatment Trials for Epithelial Ovarian Cancer, Oncology (Williston Park), vol. 19, pp. 897-898, 900, 905-906 passim, 2005.
E. L. Trimble, Rowland, J., Varricchio, C., and Gore-Langton, R. E., Clinical trials referral resource. Health-related quality of life in cancer clinical trials (Part II), Oncology, vol. 15, pp. 601-3606-8 611, 2001.
E. L. Trimble, Rowland, J., Varricchio, C., and Gore-Langton, R. E., Clinical trials referral resource. Health-related quality of life in cancer clinical trials (Part I), Oncology, vol. 15, pp. 456-861-6, 2001.
J. V. Tricoli, Schoenfeldt, M., and Conley, B., Detection of prostate cancer and predicting progression: current and future diagnostic markers, Clinical Cancer Research, vol. 10, pp. 3943-3953, 2004.
J. J. Treanor, Wilkinson, B. E., Masseoud, F., Hu-Primmer, J., Battaglia, R., O’Brien, D., Wolff, M., Rabinovich, G., Blackwelder, W., and Katz, J. M., Safety and Immunogenicity of a Recombinant Hemagglutinin Vaccine for H5 Influenza in Humans, 1999.
J. J. Treanor, Schiff, G. M., Couch, R. B., Cate, T. R., Brady, R. C., Hay, C. M., Wolff, M. C., She, D., and Cox, M. J. C., Dose-Related Safety and Immunogenicity of A Trivalent Baculovirus-Expressed Influenza-Virus Hemagglutinin Vaccine in Elderly Adults, J Infec Dis, vol. 193, pp. 1223-1228, 2006.
J. Treanor, Keitel, W., Belshe, R., Campbell, J., Schiff, G., Zangwill, K., Wolff, M., Klimov, A., Levandowski, R., and Lambert, L., Evaluation of a Single Dose of Half Strength Inactivated Influenza Vaccine in Healthy Adults, Vaccine, vol. 20, pp. 1099-1105, 2002.
J. J. Treanor, Wilkinson, B. E., Masseoud, F., Hu-Primmer, J., Battaglia, R., O’Brien, D., Wolff, M., Rabinovich, G., Blackwelder, W., and Katz, J. M., Safety and Immunogenicity of a Recombinant Hemagglutinin Vaccine for H5 Influenza in Humans, Vaccine, vol. 19, pp. 1732-1737, 2001.
J. J. Treanor, Atmar, R. L., Frey, S. E., Gormley, R., Chen, W. H., Ferreira, J., Goodwin, R., Borkowski, A., Clemens, R., and Mendelman, P. M., A Novel Intramuscular Bivalent Norovirus Virus-Like Particle Vaccine Candidate-Reactogenicity, Safety, and Immunogenicity in a Phase 1 Trial in Healthy Adults, J Infect Dis, vol. pii: jiu33, 2014.
J. J. Treanor, Campbell, J., Zangwill, K. M., Rowe, T., and Wolff, M. C., Safety and Immunogenicity of an Inactivated Subvirion Influenza A (H5N1) Vaccine, N Engl J Med, vol. 354, pp. 1343-1351, 2006.